
Toronto-based Biossil has become Canada’s newest AI unicorn after raising US$153 million in a round led by OpenAI, betting that artificial intelligence can find new uses for drugs that failed in late-stage clinical trials — and potentially turn pharmaceutical castoffs into medical breakthroughs.Plus, luxury brands like Prada, Chanel, and Louis Vuitton are spending millions to take their wealthiest customers on exclusive trips and experiences, as a slowdown among aspirational shoppers pushes the industry to focus on the small group of buyers who account for an outsized share of sales.And in The Big Picture: Nvidia launches a tool to rein in rogue AI agents, Canada’s competition watchdog investigates grocery pricing policies, SpaceX sends its massive Starship rocket into orbit, Stelco lays off 350 workers, the FBI offers a US$1 million reward in the Nijjar case, the U.S. and China remove tariffs on billions in goods, and more.The Peak Daily is produced in partnership with reframevid.com
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Private matters 🪧 - Tech companies protest lawful access bill, Ottawa tightens MAID requirements.

Toothaches 🦷 - Dentalcare needs a checkup, AI’s uneven benefits in the workplace.

Buying Canadian-ish 🇨🇦 - Ottawa struggles to Buy Canadian, lab Lleak in Russia

📈 Stirring the pot
Free AI-powered recaps of The Peak Daily and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.